A New Culture Model for Enhancing Estrogen Responsiveness in HR+ Breast Cancer Cells through Medium Replacement: Presumed Involvement of Autocrine Factors in Estrogen Resistance

Hormone receptor-positive breast cancer (HR+ BC) cells depend on estrogen and its receptor, ER. Due to this dependence, endocrine therapy (ET) such as aromatase inhibitor (AI) treatment is now possible. However, ET resistance (ET-R) occurs frequently and is a priority in HR+ BC research. The effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Seok-Hoon, Paek, Se Hyun, Kim, Jong-Kyu, Seong, Je Kyung, Lim, Woosung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253977/
https://www.ncbi.nlm.nih.gov/pubmed/37298425
http://dx.doi.org/10.3390/ijms24119474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253977/
https://www.ncbi.nlm.nih.gov/pubmed/37298425
http://dx.doi.org/10.3390/ijms24119474

Ejemplares similares